Eaton Vance Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $80.2M | Sell |
1,462,963
-232
| -0% | -$12.7K | 0.12% | 173 |
|
|
2022
Q2 | $96.7M | Sell |
1,463,195
-9,880
| -0.7% | -$653K | 0.14% | 156 |
|
|
2022
Q1 | $97.7M | Buy |
1,473,075
+1,234
| +0.1% | +$81.9K | 0.11% | 182 |
|
|
2021
Q4 | $85.7M | Buy |
1,471,841
+28,853
| +2% | +$1.68M | 0.1% | 194 |
|
|
2021
Q3 | $86M | Buy |
1,442,988
+1,210,286
| +520% | +$72.2M | 0.12% | 173 |
|
|
2021
Q2 | $13.9M | Sell |
232,702
-6,298
| -3% | -$377K | 0.02% | 532 |
|
|
2021
Q1 | $11.9M | Buy |
239,000
+457
| +0.2% | +$22.7K | 0.02% | 534 |
|
|
2020
Q4 | $11.9M | Buy |
238,543
+3,830
| +2% | +$191K | 0.02% | 504 |
|
|
2020
Q3 | $12.9M | Sell |
234,713
-1,204
| -0.5% | -$66K | 0.02% | 438 |
|
|
2020
Q2 | $12.5M | Sell |
235,917
-182,504
| -44% | -$9.65M | 0.03% | 411 |
|
|
2020
Q1 | $18.7M | Sell |
418,421
-328,683
| -44% | -$14.7M | 0.05% | 307 |
|
|
2019
Q4 | $37.3M | Sell |
747,104
-24,310
| -3% | -$1.21M | 0.07% | 235 |
|
|
2019
Q3 | $34.4M | Buy |
771,414
+208,094
| +37% | +$9.27M | 0.07% | 232 |
|
|
2019
Q2 | $23.3M | Buy |
563,320
+129,563
| +30% | +$5.35M | 0.05% | 283 |
|
|
2019
Q1 | $17.5M | Buy |
+433,757
| New | +$17.5M | 0.04% | 309 |
|